What is DexCom (DXCM)?
DexCom is a medical device company specializing in continuous glucose monitoring (CGM) systems for diabetes management. Its products provide real-time glucose data to patients and healthcare providers, facilitating improved glycemic control and treatment decisions. DexCom's CGM systems consist of wearable sensors that measure glucose levels in interstitial fluid and transmit data to display devices or mobile applications. The company focuses on advancing sensor accuracy, ease of use, and integration with other diabetes management technologies. DexCom collaborates with healthcare professionals and technology partners to expand the accessibility and functionality of its systems. Its innovations contribute to the broader field of diabetes care by offering alternatives to traditional blood glucose monitoring methods. DexCom's operations encompass research, development, manufacturing, and distribution of its medical devices worldwide.
DexCom Stock Price Today: Live Overview
The price today is shaped by current trades, showing DexCom at $67.70. The instrument has fluctuated between $66.66 and $67.99, posting a daily percentage change of +0.4607%.
FAQ: DexCom (DXCM)
What is the current price of DXCM stock?
The current price stands at $67.70.
Does DXCM pay dividends?
DexCom pays dividends via cash distributions (if applicable).
Does DXCM have a formal corporate presence or regional headquarters in the UAE?
DexCom operates through partners and distributors with no official UAE presence.
What is DXCM best known for?
The company is most famous for its continuous glucose monitoring systems for diabetes management.
What assets are typically shown together with DXCM?
Commonly shown alongside DXCM: L&G Ecommerce Logistics UCITS ETF, Schwab U.S. Aggregate Bond ETF, L&G Ecommerce Logistics UCITS ETF
Latest shares articles



